Selcaxen 40mg Capsule (Selpercatinib)

Selcaxen 40mg Capsule is a prescription-based targeted anticancer medicine used in the treatment of certain types of cancers, including Non-Small Cell Lung Cancer (NSCLC), thyroid cancer, medullary thyroid cancer, and certain other solid tumors. The active ingredient of Selcaxen is selpercatinib, which belongs to the drug class of kinase inhibitors. It works by blocking the function of abnormal RET proteins, which can promote the growth and spread of cancer cells. A doctor conducts genetic testing to confirm the presence of an RET alteration to progress in the therapy.

The capsule must be taken orally and swallowed whole with water and should not be crushed, chewed, or opened. The prescribed dose and duration of the Selpercatinib 40mg capsule depend on the patient's condition and response to treatment. It can also be taken with or without food. Patients are advised not to change the dosage and timings prescribed by the doctors because it can cause severe side effects.

Common side effects include dry mouth, diarrhea, constipation, nausea, tiredness, headache, swelling, increased blood pressure, rash, and changes in liver function tests. A few patients can undergo severe side effects, including liver toxicity, changes in heart rhythm, high blood pressure, and bleeding. Most of the Selpercatinib 40mg capsule side effects can leave when the body adapts to the medicine. However, report to your doctor if you experience serious side effects.

Patients must list all medicines, supplements, and herbal products that they are taking. The Selpercatinib 40mg capsule must be used under medical oversight or medical supervision only. Attend regular tests and follow-ups to monitor the medicine response and reduce side effects. Before making any adjustments, changing the dose, or stopping the treatment, consult with your doctor to maximize the benefit.

Head and neck cancer, kidney cancer, lung cancer, liver cancer, skin cancer

The human body shows undesired symptoms after taking Selpercatinib 40mg Capsule (Selcaxen). Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. It is advised to consult your doctor if these symptoms become unmanageable.
Some of the common side effects of Selcaxen are mentioned below:
● Rash
● Nausea
● Diarrhea
● Headache
● Tiredness
● Dry mouth
● Constipation
● Stomach pain
● Fluid retention
● High blood pressure
● Decreased white blood cells
● Changes in liver function tests
● Low levels of sodium and calcium

Selpercatinib 40mg Capsule (Selcaxen) is a prescription-based anticancer drug that should be administered orally. It is advised to take this Capsule after consulting your healthcare expert. This capsule should be swallowed as a whole with water. Don't crush, chew, or break it. It can be taken with or without food. Never skip a dose or double dose.

● Duke, E. S., Bradford, D., Marcovitz, M., Amatya, A. K., Mishra-Kalyani, P. S., Nguyen, E., ... & Singh, H. (2023). FDA approval summary: selpercatinib for the treatment of advanced RET fusion-positive solid tumors. Clinical cancer research, 29(18), 3573-3578.
● Subbiah, V., Wolf, J., Konda, B., Kang, H., Spira, A., Weiss, J., ... & Drilon, A. (2022). Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial. The Lancet Oncology, 23(10), 1261-1273.
● Wirth, L. J., Sherman, E., Robinson, B., Solomon, B., Kang, H., Lorch, J., ... & Cabanillas, M. E. (2020). Efficacy of selpercatinib in RET-altered thyroid cancers. New England Journal of Medicine, 383(9), 825-835.
● Zhou, C., Solomon, B., Loong, H. H., Park, K., Pérol, M., Arriola, E., ... & Goto, K. (2023). First-line selpercatinib or chemotherapy and pembrolizumab in RET fusion–positive NSCLC. New England Journal of Medicine, 389(20), 1839-1850.
● Markham, A. (2020). Selpercatinib: first approval. Drugs, 80(11), 1119-1124